Evaluation of the Effect of Telmisartan on Blood Pressure and Cardiovascular Risk Factor Index in High Risk Hypertensive Patients.
Phase of Trial: Phase III
Latest Information Update: 16 Aug 2012
At a glance
- Drugs Telmisartan; Telmisartan/hydrochlorothiazide
- Indications Cardiovascular disorders; Essential hypertension
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 08 Apr 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
- 08 Apr 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Dec 2010 Planned End Date changed from 1 Nov 2010 to 1 Dec 2010 as reported by ClinicalTrials.gov.